Cargando…

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration

PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL compositi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pertl, Laura, Kern, Sabine, Weger, Martin, Hausberger, Silke, Trieb, Markus, Gasser-Steiner, Vanessa, Haas, Anton, Scharnagl, Hubert, Heinemann, Akos, Marsche, Gunther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865135/
https://www.ncbi.nlm.nih.gov/pubmed/27171197
http://dx.doi.org/10.1371/journal.pone.0154397
_version_ 1782431736472272896
author Pertl, Laura
Kern, Sabine
Weger, Martin
Hausberger, Silke
Trieb, Markus
Gasser-Steiner, Vanessa
Haas, Anton
Scharnagl, Hubert
Heinemann, Akos
Marsche, Gunther
author_facet Pertl, Laura
Kern, Sabine
Weger, Martin
Hausberger, Silke
Trieb, Markus
Gasser-Steiner, Vanessa
Haas, Anton
Scharnagl, Hubert
Heinemann, Akos
Marsche, Gunther
author_sort Pertl, Laura
collection PubMed
description PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. METHODS: Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. RESULTS: In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-κB expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). CONCLUSIONS: The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis.
format Online
Article
Text
id pubmed-4865135
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48651352016-05-26 High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration Pertl, Laura Kern, Sabine Weger, Martin Hausberger, Silke Trieb, Markus Gasser-Steiner, Vanessa Haas, Anton Scharnagl, Hubert Heinemann, Akos Marsche, Gunther PLoS One Research Article PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. METHODS: Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. RESULTS: In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-κB expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). CONCLUSIONS: The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis. Public Library of Science 2016-05-12 /pmc/articles/PMC4865135/ /pubmed/27171197 http://dx.doi.org/10.1371/journal.pone.0154397 Text en © 2016 Pertl et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pertl, Laura
Kern, Sabine
Weger, Martin
Hausberger, Silke
Trieb, Markus
Gasser-Steiner, Vanessa
Haas, Anton
Scharnagl, Hubert
Heinemann, Akos
Marsche, Gunther
High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title_full High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title_fullStr High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title_full_unstemmed High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title_short High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
title_sort high-density lipoprotein function in exudative age-related macular degeneration
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865135/
https://www.ncbi.nlm.nih.gov/pubmed/27171197
http://dx.doi.org/10.1371/journal.pone.0154397
work_keys_str_mv AT pertllaura highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT kernsabine highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT wegermartin highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT hausbergersilke highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT triebmarkus highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT gassersteinervanessa highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT haasanton highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT scharnaglhubert highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT heinemannakos highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration
AT marschegunther highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration